What Comes Next Could Be a Once-in-a-Lifetime Opportunity

A wave of technological and financial transformation is reshaping the investment landscape. For those who understand the shifts ahead, this could be the foundation for long-term wealth creation. In this exclusive briefing, I'll show you exactly how to prepare for the challenges and opportunities ahead. You'll learn actionable strategies to protect your portfolio and position yourself for growth in the months and years to come.

Click here now to watch the full briefing and discover the steps to take today.

Terry D. Schlotterback net worth and biography

Terry Schlotterback Biography and Net Worth

Director of OrthoPediatrics

Terry Schlotterback currently serves as the Chairman of the Board for OrthoPediatrics, bringing over 30 years of experience in the orthopedic industry. Prior to coming to OrthoPediatrics Terry worked for Zimmer Medical Holdings where he served in various executive leadership positions including President of Zimmer’s Trauma and Spinal Divisions. These divisions accounted for over $250 million in annual sales for the publicly traded orthopedic company. Prior to serving as Division President, he held senior executive positions in Sales, Marketing and Research and Development. Prior to Zimmer, Mr. Schlotterback served in senior management roles for Johnson & Johnson’s Depuy Orthopedics and Sports Medicine Division, Mitek Surgical Products, where he led Research, New Product Development and Business Development and the eventual acquisition of Mitek by Johnson & Johnson. Additionally, Mr. Schlotterback currently serves on the Advisory Board for the Indiana North Central Region of Elevate Ventures. He also contributes advisory services to the local Economic Development Corporation. He is President of the Warsaw Chapter of the StepStone Angels. He received his Bachelor of Science degree in Mechanical Engineering Technology from Purdue University.

What is Terry D. Schlotterback's net worth?: The estimated net worth of Terry D. Schlotterback is at least $408,858.37 as of August 11th, 2023. Mr. Schlotterback owns 15,452 shares of OrthoPediatrics stock worth more than $408,858 as of November 22nd. This net worth approximation does not reflect any other investments that Mr. Schlotterback may own. Learn More about Terry D. Schlotterback's net worth.
How do I contact Terry D. Schlotterback?: The corporate mailing address for Mr. Schlotterback and other OrthoPediatrics executives is 2850 Frontier Drive, Warsaw IN, 46582. OrthoPediatrics can also be reached via phone at (574) 268-6379 and via email at [email protected]. Learn More on Terry D. Schlotterback's contact information.
Has Terry D. Schlotterback been buying or selling shares of OrthoPediatrics?: Terry D. Schlotterback has not been actively trading shares of OrthoPediatrics during the last quarter. Most recently, Terry D. Schlotterback sold 2,610 shares of the business's stock in a transaction on Friday, August 11th. The shares were sold at an average price of $38.25, for a transaction totalling $99,832.50. Following the completion of the sale, the director now directly owns 15,452 shares of the company's stock, valued at $591,039. Learn More on Terry D. Schlotterback's trading history.
Who are OrthoPediatrics' active insiders?: OrthoPediatrics' insider roster includes Bernei Berry, III (Director), Stephen Burns (Director), Fred Hite (CFO), Marie Infante (Director), Gregory Odle (EVP), Jennifer Pritzker (Major Shareholder), Terry Schlotterback (Director), and Mark Throdahl (CEO). Learn More on OrthoPediatrics' active insiders.
Are insiders buying or selling shares of OrthoPediatrics?: In the last twelve months, insiders at the sold shares 7 times. They sold a total of 27,253 shares worth more than $770,374.68. The most recent insider tranaction occured on August, 21st when General Counsel Daniel J Gerritzen sold 10,000 shares worth more than $293,000.00. Insiders at OrthoPediatrics own 31.8% of the company. Learn More about insider trades at OrthoPediatrics.
Information on this page was last updated on 8/21/2024.

Terry D. Schlotterback Insider Trading History at OrthoPediatrics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
8/11/2023	Sell	2,610	$38.25	$99,832.50	15,452
5/10/2021	Sell	4,700	$63.03	$296,241.00

Terry D. Schlotterback Buying and Selling Activity at OrthoPediatrics

OrthoPediatrics Company Overview

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

Today's Range

Now: $26.46

$25.38

$26.73

50 Day Range

MA: $26.67

$22.69

$32.28

2 Week Range

Now: $26.46

$22.41

$36.23

Volume

141,733 shs

Average Volume

169,186 shs

Market Capitalization

$640.75 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.16

BREAKING: NVDA loses $175 billion in 8 minutes

From Chaikin Analytics | Ad

It's a wild week for the legendary chipmaker. Nvidia just beat earnings expectations across every metric, with annual revenue up nearly 100%. So why did the stock abruptly plunge following the earnings release – losing $175 billion in just 8 minutes?

Things are about to get even stranger.